China's Sinopharm COVID-19 vaccine likely conducive to global vaccine accessibility: Indian newspaper – China

NEW DELHI, May 13 (Xinhua) — China’s Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday. The WHO last week validated the China-developed vaccine for emergency use, a move set to further expand global vaccine accessibility. According to the WHO, Sinopharm has an efficacy of about 79 percent for symptomatic and hospitalised disease for all age groups. However, it notes that since few adults aged over 60 were enrolled, the efficacy in…